WEDNESDAY, Nov. 13, 2024 (HealthDay News) -- The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb ...
Even if you you’re not diabetic or obese, can Ozempic be right for you? Ever since the weekly injectable was approved in 2017 ...
Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...
Research, Clinical, and Policy Implications Discontinuation is a common issue for many chronic therapies, but it’s ...
Weight loss drugs are incredibly sought-after, but they’re also often difficult to obtain due to limited insurance coverage ...
This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.
Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.
With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get ...
However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...